Live
- SP directs the students to set goals and pursue them
- Cyber security company CyberArk acquires Venafi for $1.54 billion
- 20 IS suspects detained in Turkey
- Delhi HC dismisses PIL seeking directions to medical professionals to reveal side effects of medicines
- PM Modi tears into Naveen Patnaik-led BJD govt in Odisha rally
- President Abinader re-elected in Dominican Republic
- Supreme Court refuses to entertain plea by a 78-year-old bedridden woman seeking to cast her vote by postal ballot
- Vasco da Gama’s Historic Voyage to India
- Oil India posts 17 pc jump in Q4 net profit
- Iran President Raisi's death: India declares one day state mourning on Tuesday
Hyderabad: Awareness session held on Thalassemia
In Telangana, approximately 4,000 patients suffering from Thalassemia are registered across hospitals, NGOs, and blood banks, their lives tethered to the constant need for transfusions.
Hyderabad : In Telangana, approximately 4,000 patients suffering from Thalassemia are registered across hospitals, NGOs, and blood banks, their lives tethered to the constant need for transfusions. With a yearly increase projected at 5-6%, the strain on our healthcare system intensifies, grappling with the demands of each new case.
On International Thalassemia Day observed on May 8, the Blood Warriors Foundation conducted awareness sessions at Mahatma Gandhi Institute of Technology, Gandipet on Wednesday. These sessions highlighted the challenges faced by patients and their families, underscoring the vital importance of comprehensive care.
From regular blood donations to quality medical treatment and emotional support, the battle against Thalassemia demands a multifaceted approach, including education and screening to identify carriers of the condition. Speaking at the session held at MGIT College, Krishna Vamshi Rajalingu, co-founder & CEO of Blood Warriors Foundation, said, “Our primary goal is to establish a robust support ecosystem for existing Thalassemia patients, while also championing awareness of preventive measures such as HPLC tests to curb the birth of new cases.”
